Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Days alive and out of hospital after treatment for oropharyngeal squamous cell carcinoma with primary transoral robotic surgery or radiotherapy - a prospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinicopathologic characteristics of Burkitt lymphoma of the head and neck in a non-endemic region-a Danish nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The impact of HPV genotypes on survival in HPV-positive oropharyngeal squamous cell carcinomas: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Danish translation of the Neck Dissection Impairment Index

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Surgical management of rhinocerebral mucormycosis: A case series

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Perfusion changes in the foot after a free fibula flap

    Research output: Contribution to journalLetterResearchpeer-review

  3. Acute Postoperative Pain Trajectory Groups: Comment

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

BACKGROUND: With the rising incidence of oropharyngeal squamous cell cancer, there is a need to assess the burden of treatment.

AIMS/OBJECTIVES: This study assessed 'days alive and out of hospital' (DAOH) in a cohort of patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with either transoral robotic surgery (TORS) or radiotherapy (RT).

MATERIAL AND METHODS: A prospective cohort study conducted between May 2017-June 2019. Primary outcome was DAOH in the first 30 days after treatment (DAOH30). The secondary outcome was DAOH180.

RESULTS: Forty-four patients were included, 31 treated with TORS and 13 with RT. Patients treated with TORS had a median DAOH30 of 25 (IQR 22.8-26) including a required four-day postoperative stay- and a median DAOH180 of 168 (IQR 163-171.3). In contrast, patients treated with RT had a median DAOH30 of 30 (IQR 26-30) and a DAOH180 of 143 days (IQR 135.5-149).

CONCLUSIONS AND SIGNIFICANCE: DAOH has not been examined in oropharyngeal cancer before. We found, patients overall spent 92.5% of the first 180 days alive and out of hospital. Patients treated with TORS had high DAOH30, which remained high in DAOH180, while patients treated with RT with reduced DAOH30, had reduced DAOH180 calling for further large-scale studies.

Original languageEnglish
JournalActa Oto-Laryngologica
Volume141
Issue number2
Pages (from-to)193-196
Number of pages4
ISSN0001-6489
DOIs
Publication statusPublished - Feb 2021

    Research areas

  • Days Alive and Out of Hospital, DAOH, oropharyngeal cancer, squamous cell carcinoma, TORS, radiotherapy

ID: 61215026